28171 Assessing long-term maintenance of efficacy with tralokinumab monotherapy in patients with moderate-to-severe atopic dermatitis: Combined results from two phase 3, randomized, double-blind, placebo-controlled trials (ECZTRA 1 and 2)

Subjects

Subjects :

Moderate to severe
medicine.medical_specialty
business.industry
Long term maintenance
Dermatology
Atopic dermatitis
Placebo
medicine.disease
Double blind
Internal medicine
medicine
In patient
business
Tralokinumab

Details

ISSN :

01909622

Volume :

85

Database :

OpenAIRE

Journal :

Journal of the American Academy of Dermatology

Accession number :

edsair.doi...........d8fce7c614af391a8f3e4e9fbc471e9c

Full Text :

https://doi.org/10.1016/j.jaad.2021.06.723